Last reviewed · How we verify

NCT05150860

Communities Fighting COVID Return to School

Completed NA Results posted Last updated 17 January 2025
What this trial tests

NA trial testing At-home COVID-19 testing in COVID-19 in 852 participants. Completed in 2 April 2022.

Timeline
17 October 2021
Primary endpoint
2 April 2022
2 April 2022

Quick facts

Lead sponsorSan Diego State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment852
Start date17 October 2021
Primary completion2 April 2022
Estimated completion2 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

San Diego State University

Who can join

2 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Adherence to the Weekly COVID-19 Testing Schedule Primary · through study completion, up to 21 weeks

Proportion of scheduled weekly COVID-19 tests completed when enrolled in the trial

GroupValue95% CI
At-home COVID-19 Testing0.394± 0.038
Onsite COVID-19 Testing0.352± 0.032

Sponsor's own description

San Diego State University (SDSU), a designated Hispanic-serving institution, is partnering with Sweetwater Union High School District, an independent public school district serving 90% ethnic minority and a high proportion of socioeconomically disadvantaged students, and other community partners, to generate evidence for effective and feasible COVID-19 testing for unvaccinated and medically vulnerable middle school students and staff as part of broader COVID mitigation strategies including vaccination to return students back to school safely.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. At-Home Versus Onsite COVID-19 School-based Testing: A Randomized Noninferiority Trial.
    Kiene SM, McDaniels-Davidson C, Lin CD, Rodriguez T, et al · · 2023 · cited 4× · PMID 37394511 · DOI 10.1542/peds.2022-060352f
  2. A Multi-Study Synthesis of Facilitators and Barriers to SARS-CoV-2 Testing Enrollment in School Settings.
    Keener Mast D, Gwynn L, Johnson SB, McDaniels-Davidson C, et al · · 2023 · cited 3× · PMID 37394502 · DOI 10.1542/peds.2022-060352j
  3. Common Data Element Collection in Underserved School Communities: Challenges and Recommendations.
    Uthappa DM, Mann TK, Goldman JL, Schuster JE, et al · · 2023 · PMID 37394503 · DOI 10.1542/peds.2022-060352n

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other San Diego State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing